ENA Respiratory

Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

ENA Respiratory is developing a novel class of innate immunomodulators that have the capability to prevent respiratory viral infections, including COVID-19 and associated complications.
The company is based in Melbourne, Australia and it has secured a Series A investment from the Brandon Capital managed Medical Research Commercialisation Fund (MRCF) and Uniseed.

Category: Hardware & devices, Health & biotech
URL: http://www.enarespiratory.com
Operational Status: Active
ASX Listing Code (if applicable):
Year of Commencement: 2020

31 Queen Street, Melbourne, Victoria 3000, AU

State: Victoria
Overseas Operations: No
Linkedin: https://www.linkedin.com/company/innavac-pty-ltd/
Key Personnel:
Awards won: